Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2013-03-15 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RayStation® 3.5 released
Regulatory Filings Classification · 95% confidence The document is a press release announcing the release of a new software version, RayStation® 3.5. It details new features, improvements, and regulatory status in various regions. This type of announcement, which is a general update about a product release rather than a formal financial filing (like 10-K, ER, or IR), fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous corporate announcement, or potentially a specialized product update not covered by the financial codes. Since it is not a financial report, earnings release, or management change, and it is a general announcement, RNS is the most appropriate fallback. It is not a Call Transcript (CT), Investor Presentation (IP), or Earnings Release (ER). Given the context of a product launch announcement, RNS serves as the best fit among the provided options for a non-financial, general corporate update.
2013-03-15 English
RayStation® 3.5 släppt
Regulatory Filings Classification · 95% confidence The document is a press release dated March 15, 2013, announcing the release of a new software version, RayStation® 3.5. It details new features, modules (Proton Beam Design, Electron Beam Design), workflow improvements (Plangenereringsprotokoll, Fallback Planning), and biological evaluation tools. This type of announcement, detailing a new product release or major update, is typically classified as a general announcement or a regulatory filing if it doesn't fit a more specific category like Earnings Release (ER) or Capital Update (CAP). Since it is a specific product/technology update and not a standard financial report (10-K, IR, ER), nor a management change (MANG) or dividend notice (DIV), it falls best under the general Regulatory Filings (RNS) category, which serves as a fallback for specific operational or product news releases that are not covered elsewhere. The length (6636 chars) is substantial enough that it is the report itself, not just an announcement of a report (RPA).
2013-03-15 Swedish
Major Shareholding Notification 2013
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder ('Home Capital AS') in RaySearch Laboratories AB (publ). It explicitly states the 'Reason for major shareholding notification Sell' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage of voting rights. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2013-02-27 English
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 95% confidence The document is a 'Bokslutskommuniké' (Year-end Report) for RaySearch Laboratories AB for the period 1 January – 31 December 2012. It contains comprehensive financial statements, including income statements, cash flow data, and detailed management commentary on business performance, market expansion, and future outlook. As it provides substantive financial data for a period shorter than a full fiscal year (or in this case, the final quarterly/annual summary before the full audited report), it falls under the category of an Interim/Quarterly Report. FY 2012
2013-02-14 Swedish
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is a 'Year-End Report' for RaySearch Laboratories AB for the period January 1 – December 31, 2012. It contains comprehensive financial statements, including income statements, balance sheet data, and detailed management commentary on business performance, market expansion, and future outlook. As it covers a full fiscal year and provides substantive financial data, it is classified as an Interim/Quarterly Report (IR) in the context of financial reporting standards, as it serves as the primary financial disclosure for the period. FY 2012
2013-02-14 English
First RayStation order in France
Regulatory Filings Classification · 96% confidence The document is a press release dated February 1, 2013, announcing a specific business event: receiving an order for the RayStation® treatment planning system from a French cancer institute (ICLN). This is a specific operational update concerning a customer acquisition and product deployment, not a general financial report (like 10-K, IR, ER), a management change (MANG), or a shareholder vote result (DVA). It is a specific business announcement. Since there is no category for 'Business Contract Announcement' or 'Sales Update', the most appropriate general category for a specific, non-financial, non-regulatory announcement that doesn't fit other specific codes is 'Regulatory Filings' (RNS), which serves as a miscellaneous regulatory/announcement fallback. However, given the content is a press release detailing a significant business event (a major order), it is often classified under the closest relevant category if available. Since it is not a dividend (DIV), capital change (CAP/SHA), director dealing (DIRS), or M&A (TAR), and it's not a transcript (CT) or presentation (IP), RNS is the best fit as a general regulatory/public announcement fallback.
2013-02-01 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.